Interphex 2011 Unveils Speakers, Special Events, Education, Exhibits


Mar 08, 2011

Interphex 2011, which will be held at New York’s Jacob K. Javits Convention Center March 29 – 31, will feature more than 650 suppliers (including more than 100 new exhibitors). The event will be segmented into four exhibit zones: Facilities; Sourcing & Services; Automation: Systems & Controls; and Manufacturing & Packaging.

The show also will host The Signature Series, a two-day lineup of programs and interviews with global experts. The series includes:

  • Challenges for Continuous Processing: Moheb Nasr, director, Office of new Drug Quality Assessment, CDER, FDA; Alex Cheung, director/team leader of the Technology, Science and Operations Group, Pfizer Global Supply Division, Pfizer Inc.; Fernando Muzzio, professor Chemical Engineering, Rutgers University and president, Mixing Consultants, Inc.
  • The Future for a Fully Integrated Platform: James Evans, associate director Novartis-MIT Center for Continuous Manufacturing
  • Automating Stem-Cell Manufacturing: Bob Speziale, vice president Business Development, Invetech
  • China: The New Pharma Frontier: Xiong Yu, vice president, China Institute for the Pharmaceutical Industry (CIPI); Feng Li, senior vice president, Advanced Pharmaceuticals. Presented in conjunction with Advanced Pharmaceuticals.
  • Jim Miller on Outsourcing: Jim Miller, president and CEO, PharmSource and Outsourcing Columnist, Pharmaceutical Technology and a respected outsourcing consultant, returns to Interphex for his annual review of important trends for contract providers. This will be held in Room #1E07.
  • Outsourcing Discussion: Mark Scheftel, executive director, Direct Materials Procurement, Merck Global Procurement; Peter T. Bigelow, president, North American Operations, Patheon. Moderated by Jim Miller. On the Main Stage.

For more information, visit:

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments